CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

80,000 per cent multibagger returns; Board likely to announce bonus shares!
DSIJ Intelligence-1

80,000 per cent multibagger returns; Board likely to announce bonus shares!

The stock gave multibagger returns of 300 per cent in just 1 year, 4,200 per cent in 5 years and a whopping 80,000 per cent in a decade.

Shukra Pharmaceuticals Ltd inform you that the meeting of the Board of Directors of the company is scheduled to be held on Thursday, February 29, 2024, at the Registered Office of the company inter alia to consider and approve the following:

  • To consider and approve the proposal for issuance of fully paid-up bonus equity shares to the members of the company subject to necessary approval.
  • To consider and approve the proposal of an increase in the authorized share capital of the company and subsequent alteration to the memorandum of association of the company. if needed, subject to necessary approval.
  • To consider and finalize the matters to be included in the notice of EGM/Postal ballot including day, date, place & time, if required.

Today, shares of Shukra Pharmaceuticals Ltd were locked in a 5 per cent upper circuit to Rs 250.40 per share from its previous closing of Rs 238.50. The stock also traded at a new 52-week high of Rs 250.40.  

Established in 1993, Shukra Pharmaceuticals Ltd. operates in both manufacturing and trading pharmaceuticals, alongside offering laboratory testing services. The company has a market cap of over Rs 250 crore with a 3-year stock price CAGR of 200 per cent.

DSIJ’s ‘Micro Marvel' service recommends micro-cap stocks with the potential to grow multifold in long run. If this interests you, do download the service details here.

The company reported positive results in both quarterly and annual financial statements. In Q3FY24, net sales rose by 721 per cent to Rs 18.89 crore and net profit skyrocketed 314 times to Rs 9.42 per cent compared to Q3FY23. In FY22, the company did net sales of Rs 20.48 crore and net profit skyrocketed 295 per cent.

According to the shareholding, the promoters own a 50.95 per cent stake in the company while DIIs own 0.11 per cent and the public owns 48.94 per cent as of December 2023. The stock gave multibagger returns of 300 per cent in just 1 year, 4,200 per cent in 5 years and a whopping 80,000 per cent in a decade. Investors should keep an eye on this micro-cap stock.

Disclaimer: The article is for informational purposes only and not investment advice.

For more such updates on the go, Click here to join our WhatsApp Channel

Previous Article Right approach to analyse open interest in options trading - Insights no one would tell you!
Next Article 1,200 per cent returns and promoters & FIIs increase stake: Heavy buying in this multibagger aerospace & defence stock; hit upper circuit on February 26
Print
18197 Rate this article:
4.1
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR